|
TBC1D5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62625468647093E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.52446977053478E-13 |
| Normal-vs-Stage2 |
2.62380000004558E-06 |
| Normal-vs-Stage3 |
2.70117261891301E-13 |
| Normal-vs-Stage4 |
1.86050064243659E-11 |
| Stage1-vs-Stage2 |
2.833800E-01 |
| Stage1-vs-Stage3 |
1.328630E-01 |
| Stage1-vs-Stage4 |
8.789900E-02 |
| Stage2-vs-Stage3 |
4.083800E-02 |
| Stage2-vs-Stage4 |
2.901500E-02 |
| Stage3-vs-Stage4 |
7.566000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.10862446895044E-15 |
| Normal-vs-AfricanAmerican |
2.793400E-04 |
| Normal-vs-Asian |
3.6416999971145E-08 |
| Caucasian-vs-AfricanAmerican |
3.354000E-01 |
| Caucasian-vs-Asian |
8.415400E-01 |
| AfricanAmerican-vs-Asian |
4.989800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.45008482788489E-13 |
| Normal-vs-Female |
1.66344715779587E-12 |
| Male-vs-Female |
2.184000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.25030002912285E-11 |
| Normal-vs-Age(41-60Yrs) |
8.30446822419617E-14 |
| Normal-vs-Age(61-80Yrs) |
9.36395405659596E-12 |
| Normal-vs-Age(81-100Yrs) |
1.624890E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.288400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.769600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.559800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.037400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.304400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.898400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.895600E-02 |
| Classical-VS-Follicular |
7.495200E-01 |
| Classical-VS-Other |
2.622400E-01 |
| Classical-VS-Normal |
1.77780012933226E-12 |
| Tall-VS-Follicular |
2.850100E-02 |
| Tall-VS-Other |
9.448400E-01 |
| Tall-VS-Normal |
1.33109967492828E-10 |
| Follicular-VS-Other |
2.910000E-01 |
| Follicular-VS-Normal |
4.55630000395502E-08 |
| Other-VS-Normal |
6.038800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.02260430626211E-12 |
| Normal-vs-N1 |
3.53872486869022E-12 |
| N0-vs-N1 |
3.197500E-02 |
|
|
